Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-08 08:12 am Sale | 2025-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Federated Hermes, Inc. FHI | 3,303,640 11.630% | -1,407,872 (-29.88%) | Filing History |
| 2025-12-29 08:29 am Purchase | 2025-12-22 | 13G | MINERVA NEUROSCIENCES INC NERV | Federated Hermes, Inc. FHI | 9,392,275 19.860% | 8,041,000 (+595.07%) | Filing History |
| 2025-11-05 10:28 am Purchase | 2025-10-31 | 13G | MGP INGREDIENTS, INC MGPI | Federated Hermes, Inc. FHI | 1,101,767 5.170% | 1,101,767 (New Position) | Filing History |
| 2025-10-28 4:39 pm Unchanged | 2025-10-21 | 13D | MINERVA NEUROSCIENCES INC NERV | Federated Hermes, Inc. FHI | 1,351,275 19.320% | 0 (Unchanged) | Filing History |
| 2025-10-07 11:14 am Sale | 2025-09-30 | 13G | SOUNDTHINKING, INC. SSTI | Federated Hermes, Inc. FHI | 1,000,000 7.820% | -315,000 (-23.95%) | Filing History |
| 2025-10-07 11:11 am Sale | 2025-09-30 | 13G | SCYNEXIS INC SCYX | Federated Hermes, Inc. FHI | 639,575 11.260% | -163,956 (-20.40%) | Filing History |
| 2025-10-07 11:08 am Purchase | 2025-09-30 | 13G | FORTE BIOSCIENCES INC FBRX | Federated Hermes, Inc. FHI | 1,635,380 13.150% | 156,733 (+10.60%) | Filing History |
| 2025-10-07 11:03 am Sale | 2025-09-30 | 13G | ATYR PHARMA INC ATYR | Federated Hermes, Inc. FHI | 10,544,437 10.760% | -4,122,163 (-28.11%) | Filing History |
| 2025-09-05 09:38 am Purchase | 2025-08-31 | 13G | FORTE BIOSCIENCES INC FBRX | Federated Hermes, Inc. FHI | 1,478,647 11.890% | 406,414 (+37.90%) | Filing History |
| 2025-07-08 07:50 am Purchase | 2025-06-30 | 13G | FORTE BIOSCIENCES INC FBRX | Federated Hermes, Inc. FHI | 1,072,233 8.780% | 1,072,233 (New Position) | Filing History |
| 2025-07-08 07:30 am Purchase | 2025-06-30 | 13G | EYEPOINT INC EYPT | Federated Hermes, Inc. FHI | 4,599,450 6.680% | 892,086 (+24.06%) | Filing History |
| 2025-06-04 09:19 am Sale | 2025-05-31 | 13G | VIRGIN GALACTIC HLDGS INC SPCE | Federated Hermes, Inc. FHI | 209,985 0.510% | -1,746,214 (-89.27%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | FEDERATED HERMES, INC. FHI | BlackRock, Inc. BLK | 5,219,607 6.400% | -3,339,600 (-39.02%) | Filing History |
| 2025-04-07 10:44 am Purchase | 2025-03-31 | 13G | VIRGIN GALACTIC HLDGS INC SPCE | Federated Hermes, Inc. FHI | 1,956,199 5.510% | 1,956,199 (New Position) | Filing History |
| 2025-01-08 1:46 pm Sale | 2024-12-31 | 13G | SCYNEXIS INC SCYX | Federated Hermes, Inc. FHI | 803,531 15.500% | -87,500 (-9.82%) | Filing History |
| 2025-01-08 1:38 pm Unchanged | 2024-12-31 | 13G | ATYR PHARMA INC ATYR | Federated Hermes, Inc. FHI | 14,666,600 17.470% | 0 (Unchanged) | Filing History |
| 2024-11-06 08:56 am Unchanged | 2024-10-31 | 13G | SCYNEXIS INC SCYX | Federated Hermes, Inc. FHI | 891,031 17.220% | 0 (Unchanged) | Filing History |
| 2024-11-06 08:54 am Purchase | 2024-10-31 | 13G | EYEPOINT INC EYPT | Federated Hermes, Inc. FHI | 3,707,364 5.440% | 3,707,364 (New Position) | Filing History |
| 2024-10-07 1:38 pm Sale | 2024-09-30 | 13G | SCYNEXIS INC SCYX | Federated Hermes, Inc. FHI | 891,031 18.830% | -120,807 (-11.94%) | Filing History |
| 2024-10-07 1:36 pm Purchase | 2024-09-30 | 13G | ATYR PHARMA INC ATYR | Federated Hermes, Inc. FHI | 14,666,600 19.350% | 4,497,000 (+44.22%) | Filing History |